{"product_id":"leni-ret-10mg","title":"Retatrutide — 10 mg","description":"\u003cp class=\"leni-copy-opening\"\u003eRetatrutide has a lot going on in the science department. Before the acronyms start taking over the room, let’s give them a proper introduction. Curiosity looks good on you.\u003c\/p\u003e\u003ch2\u003eThe quick version.\u003c\/h2\u003e\u003cp\u003eRetatrutide is being investigated for activity at GIP, GLP-1 and glucagon receptors. You may see that described as a “triple agonist”. It refers to three receptor pathways. It does not translate into three times the benefit or a shortcut to a particular outcome.\u003c\/p\u003e\u003cp\u003eHuman clinical research has examined retatrutide in weight management. The published phase 2 study is one reference point for understanding that work. Research findings describe a specified study product, population and protocol; they do not certify a supplier vial with the same compound name.\u003c\/p\u003e\u003ch2\u003eOkay, tell me more.\u003c\/h2\u003e\u003cp\u003eWe place retatrutide in weight-management research. The research part matters: this is an investigational compound, and the science should be read in that context. Rather than treating a study headline as the whole story, look at who took part, what was measured and what remains uncertain. A little context is much more useful than a very big headline. The product details below keep the proposed presentation separate from the research discussion.\u003c\/p\u003e\u003ch2\u003eThe finer points.\u003c\/h2\u003e\u003cp\u003eYou’re a details girl. We respect it. Here’s what we know, with the gaps clearly marked. No detective work required.\u003c\/p\u003e\u003cdiv class=\"leni-spec-table\"\u003e\u003ctable\u003e\n\u003ccaption\u003eProduct specifications — draft\u003c\/caption\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003eCompound\u003c\/th\u003e\n\u003ctd\u003eRetatrutide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003eProposed total content\u003c\/th\u003e\n\u003ctd\u003e10 mg per vial — supplier confirmation pending\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003ePresentation\u003c\/th\u003e\n\u003ctd\u003eProposed vial; exact form and retail pack size pending\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003eFormulation \/ chemical form\u003c\/th\u003e\n\u003ctd\u003eTo be confirmed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003eBatch \/ manufacturer \/ expiry\u003c\/th\u003e\n\u003ctd\u003eCurrent-batch details pending\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003eIdentity \/ content \/ purity\u003c\/th\u003e\n\u003ctd\u003eCurrent-batch verification pending\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003eSterility \/ endotoxin\u003c\/th\u003e\n\u003ctd\u003eNot verified\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth scope=\"row\"\u003eStorage \/ stability\u003c\/th\u003e\n\u003ctd\u003eProduct-specific information pending\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\u003c\/div\u003e\u003cdiv class=\"leni-good-to-know\"\u003e\n\u003ch2\u003eGood to know.\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is investigational. Safety, suitability and outcomes for this proposed supplier product are not established by the ingredient’s research history. It should not be described as a proven upgrade to another medicine or as having predictable results for an individual.\u003c\/p\u003e\n\u003c\/div\u003e\u003ch2\u003eThe questions in your 27 open tabs.\u003c\/h2\u003e\u003cp\u003eLet’s close a few of them, shall we?\u003c\/p\u003e\u003cdetails class=\"leni-faq\"\u003e\u003csummary\u003eWhat does “triple agonist” actually mean?\u003c\/summary\u003e\u003cp\u003eIt describes activity at three receptor types: GIP, GLP-1 and glucagon. It is a mechanism label, not a ranking, performance score or promise.\u003c\/p\u003e\u003c\/details\u003e\u003cdetails class=\"leni-faq\"\u003e\u003csummary\u003eIs research on retatrutide research on this vial?\u003c\/summary\u003e\u003cp\u003eNo. A study uses a defined study product. Its results cannot authenticate the identity, content, formulation or quality of a separate supplier vial.\u003c\/p\u003e\u003c\/details\u003e\u003cdetails class=\"leni-faq\"\u003e\u003csummary\u003eWhy keep the word “research” in the category?\u003c\/summary\u003e\u003cp\u003eBecause it tells you something useful about the evidence context. We want the heading to help you understand the information, rather than make the science sound more settled than it is.\u003c\/p\u003e\u003c\/details\u003e\u003cdetails class=\"leni-faq\"\u003e\u003csummary\u003eIs the amount on the vial a suggested dose?\u003c\/summary\u003e\u003cp\u003eNo. The proposed 10 mg is the total content of the vial, not a dose, concentration or number of uses. This page does not provide preparation or dosing instructions.\u003c\/p\u003e\u003c\/details\u003e\u003cdetails class=\"leni-faq\"\u003e\u003csummary\u003eWhere are the rest of the specifications?\u003c\/summary\u003e\u003cp\u003eSome details are still pending for this draft. We have marked them in the table instead of filling in the blanks with assumptions. Exact batch documents and product-specific information need to match the item.\u003c\/p\u003e\u003c\/details\u003e\u003cp class=\"leni-copy-signoff\"\u003eThere we go. A little less alphabet soup.\u003c\/p\u003e","brand":"Leni","offers":[{"title":"Default Title","offer_id":67682100150524,"sku":"LENI-RET-10MG","price":229.0,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0827\/3910\/1948\/files\/leni-retatrutide-clean.png?v=1791689403","url":"https:\/\/lenihealth.com.au\/products\/leni-ret-10mg","provider":"Leni Health","version":"1.0","type":"link"}